Hepatitis, Viral, Non-A, Non-B, Parenterally-Transmitted Clinical Trial
Official title:
Factors Associated to Success of Hepatitis C Therapy
The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin, and to investigate the associated factors with RVS, by means of retrospective analysis.
Chronic hepatitis C virus(HVC) is a major public-health problem since it presents a long phase of clinical latency which makes its early diagnosis difficult and results in the development of a large number of cases to complications such as cirrhosis, hepatic insufficiency and hepatocarcinoma. In Brazil, it is estimated three million estimated cases to 52 thousand reports. The aim of this study is to evaluate the sustained virologic response (RVS) in HVC patients treated with pegylated-interferon or conventional-interferon and ribavirin, and to investigate the associated factors with RVS, by means of retrospective analysis. ;
Observational Model: Cohort, Time Perspective: Retrospective
| Status | Clinical Trial | Phase | |
|---|---|---|---|
| Completed |
NCT02113865 -
Score System for Prediction Risk and Early Diagnosis of HCC in HIV/HCV Patients
|
N/A | |
| Completed |
NCT00512941 -
Laboratory Profile of Hepatitis B and C in Users of a Reference Service
|
N/A | |
| Active, not recruiting |
NCT00499434 -
Correlation Between Cytokines and Hepatic Histology in Patients Infected by HIV-1 and the Hepatitis-C Virus
|
N/A |